Vevo MD , the first Ultra High Frequency (UHF) clinical ultrasound system, secures 510(k) clearance from FDA-FUJIFILM VisualSonics Inc.

FUJIFILM VisualSonics Inc., a world leader in ultra high frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., announced 510(k) clearance from the FDA for its Vevo MD, the world’s first Ultra High Frequency (UHF) clinical ultrasound system.The Vevo MD is FUJIFILM VisualSonics’ first foray into the clinical market.

First commercialized in Europe, the Vevo MD is truly a unique ultrasound system, as it operates at much higher frequencies than any conventional ultrasound system currently available. It allows medical professionals to see what they have never seen before—unparalleled image resolution down to 30 micrometers. The Vevo MD system is compatible with FUJIFILM VisualSonics UHF series of transducers. This patented transducer technology is capable of operating in a range of frequencies up to 70 MHz, a tremendous increase in resolution compared to conventional ultrasound systems. The Vevo MD was designed to play a role in a range of clinical application areas including neonatology, vascular, musculoskeletal, dermatology, and other small parts that are within the first 3 cm of the body.